We compared low-density lipoprotein cholesterol (LDL) values obtained by the Friedewald formula-i.e., total cholesterol minus high-density lipoprotein (HDL) cholesterol minus very-low-density lipoprotein (VLDL) cholesterol (estimated as triglyceride -5)-with those obtained by lipoprotein fractionation, using 4736 specimens. When triglycerides were <2.0 g/L, >90% of estimated LDL cholesterol values were acceptable, within ± 10% of measured values. At triglyceride concentrations of 2.0-4.0 g/L and 4.0-6.0 g/L, only 72% and 39%, respectively, of the estimates were acceptable. LDL values derived from an alternative formula, estimating VLDL as triglycerides --6, were even less accurate. Nevertheless, the use of estimated LDL for risk classification based on the National Cholesterol Education Program Adult Treatment Panel cutpoints of 1.30 and 1.60 g/L was considered acceptable. At triglyceride concentrations 5.0 g/L, 88% of classifications based on estimated LDL (using triglycerides #{247} 5) were concordant with those by measured LDL. Eleven percent of classifications were shifted across one cutpoint, evenly distributed between high and low. Fewer than 1% of classifications, all with Type Ill hyperlipoproteinemia, were misclassified two cutpoints high. Refinements in the estimation model did not substantially improve LDL estimation or concordance of risk classification. model derived from our own data set were compared with measurements by lipoprotein fractionation. We also examined the concordance of classification in relation to the NCEP LDL cutpoints between measured LDL and LDL derived by the estimation models to determine whether different methods of estimation would affect a patient's classification for risk of heart disease.
Health and Nutrition Examination Survey (4), from which the NCEP cutpoints were derived (1). This convenient model is based on the fact that most of the circulating triglyceride is carried in the VLDL fraction, the composition of which is relatively constant. The method is not without limitations; in cases of dysbetalipoproteinemia (Type Ill hyperlipoproteinemia), which are characterized by substantial cholesterol enrichment in the VLDL, the VLDL cholesterol is underestimated and hence LDL is overestimated (3). On the other hand, specimens with chylomicronemia or high concentrations of VLDL tend to have a lower proportion of cholesterol, so the formula overestimates VLDL and underestimates LDL cholesterol.
Moreover, fasting is considered a requirement for LDL estimation, because nonfasting patients may exhibit chylomicronemia or increased concentrations of triglyceriderich particles, contributing to errors in estimation (5) .
Since the Friedewald estimation procedure
was published, evaluations in various populations (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) have demonstrated its limitations, and alternatives have been proposed involving different factors or more-sophisticated formulas (6, 9, 11, 12). In some cases specific models have been recommended for population subsets by categories of age, gender, and concentrations of triglyceride and cholesterol (13, 14) .
In the alternative model that has attracted the most attention, that of DeLong et al. (17) , 95 (8%) of 1124 reporting laboratories used this formula; all other participating laboratories used the conventional Friedewald formula.
Now that LDL cholesterol has assumed increased importance in the NCEP guidelines, its accurate quantification is important. To determine the reliability of LDL estimation procedures, we examined data from referral patients and research subjects for which lipoprotein fractionations were completed at the Northwest Lipid Research Center. Estimates of LDL cholesterol by the conventional Friedewald equation (VLDL = triglyceride #{247} 5), the alternative DeLong equation (triglyceride #{247} 6), and another multiple regression model derived from our own data set were compared with measurements by lipoprotein fractionation. We also examined the concordance of classification in relation to the NCEP LDL cutpoints between measured LDL and LDL derived by the estimation models to determine whether different methods of estimation would affect a patient's classification for risk of heart disease.
Methods and Materials

Study Database
Results for all specimens received for analysis at the NWLRC Lipoprotein Laboratory from July 1987 to the present are contained in a computerized database. 
From
Results and DIscussIon
Formulas for estimation of VLDL cholesterol are based on an assumption of uniform specimen composition, with a relatively consistent relationship with triglyceride. The DeLong (triglyceride #{247} 6) formula (11) was derived from the Lipid Research Clinics Prevalence Study, in which the non-enzymic Kessler method was used in the AutoAnalyzer II (Technicon Corp., Tarrytown, NY) (2). Specimens were extracted into isopropyl alcohol and zeolite, which removed a variable amount but not all of the free glycerol. Although the non-enzymic method was capable of correcting for the remaining free glycerol, this was not done in the results from the LRC Prevalence Study. Thus the triglyceride values from which the DeLong formula was derived were only partly corrected for free glycerol, perhaps contributing to the larger denominator. Another factor might be method biases from the non-enzymic This is demonstrated in Figure 3 . Cross tabulations comparing classification based on measured LDL to that based on estimated LDL by the three models for subjects with triglycerides 5.0 g/L demonstrated reasonable concordance. Eighty-eight percent of the classifications based on estimated LDL cholesterol were in concordance with those based on measured LDL when the Friedewald (triglyceride #{247} 5) model was used. An additional 5% were classified one cutpoint low, and 6% were classified one cutpoint high. Only 18 subjects (0.4%) were classified two cutpoints high, and all of these were diagnosed as Type ifi, appropriate candidates for treatment irrespective of their LDL cholesterol values. Limiting the comparison to only those cases with triglyceride concentrations 4.0 g/L increased the concordant proportion only from 88% to 89%.
When we used the DeLong (triglyceride #{247} 6) model, 86% of the subjects were classified in concordance with that based on measured LDL cholesterol. As might be expected, the misclassification was skewed high. Only 2% were misclassified one cutpoint low compared with 11% misclassified one cutpoint high. A total of 26 subjects (0.6%) were misclassified two cutpoints high.
The interaction regression model gave results quite similar to those for the Friedewald (triglyceride #{247} 5) model, with 89% classified in concordance, 6% classified one cutpoint low, 6% classified one cutpoint high, and 0.3% classified two cutpoints high. Thus this model, which modestly TGI5 in our experience the contribution of free glycerol is too small to justify using the triglyceride #{247} 6 formula.
The NCEP Adult Treatment Panel recommended that triglyceride concentrations >5.0 g/L be considered abnormally high. Patients with triglyceride concentrations exceeding this cutpoint should be treated at least for the hypertriglyceridemia, regardless of the LDL cholesterol value. Many subjects with triglyceride concentrations >5.0 gIL will have low LDL, often <1.30 gIL. In addition, patients with high values for both triglycerides and cholesterol will often be referred for complete lipoprotein quantification, which provides an accurate LDL cholesterol ineasurement and allows for detection of Type ifi hyperlipidemia. Thus, the cutpoint of 5.0 g/L would appear to be a value above which reliable estimation of LDL cholesterol might be considered less important.
Of particular concern is that classification based on LDL cholesterol be reliable in the majority of patients with triglycerides 5.0 gIL. Our results suggest that changing the accepted upper triglyceride limit for the Friedewald estimation from 4.0 to 5.0 gIL would not significantly impair classification.
The presence of chylomicrons is considered an exclusion for using the Friedewald formula. We did not evaluate this source of interference. However, chylomicrons in a specimen with triglycerides 5.0 g/L would almost always be a result of not fasting, and would lead to an error in estimation (5). Thus, the presence of chylomicrons, which can easily be detected visually, signals an inappropriate specimen.
In summary, while the use of the Friedewald formula for estimating VLDL cholesterol and LDL cholesterol becomes less reliable as the triglyceride concentration increases, the concordance of classification based on the National Cholesterol Education Program Adult Treatment Panel cutpoints is quite good. The Friedewald formula would appear to be adequate for continued use in patient classification.
